MAP kinase phosphatase-1 - a new player at the nexus between









































Skeletal muscle is a major contributor to resting levels 
of energy expenditure [1], and reduced skeletal muscle 
function contributes to age-induced obesity and 
diabetes. Disruption of skeletal muscle function may 
also contribute to insulin resistance and diabetes caused 
by overnutrition and obesity [2]. There is increasing 
evidence that similar molecular pathways are at work in 
promoting age-related and obesity-related muscle 
dysfunction. These pathways seem to converge at the 











































The overall metabolic capacity of skeletal muscle is 
determined by the myofiber type of the particular muscle. 
Though less abundant, oxidative/slow twitch (MHC type 
I, IIa) muscle fibers are important for overall metabolic 
wellness. However, the most abundant myofibers are 
glycolytic or fast twitch (MHC type IIx/IIB) muscle 
fibers which mainly utilize glycolysis to metabolize 
glucose. Oxidative myofibers have increased 
mitochondria, more blood flow, and are resistant to 
fatigue. In contrast, glycolytic fibers have the least 
amount of mitochondria, and fatigue easily [2, 3]. 
 






















Abstract:  Sarcopenia,  which  is  defined  by  the  loss  of  skeletal  muscle  mass, predisposes  skeletal  muscle  to metabolic
dysfunction which can precipitate metabolic disease. Similarly, overnutrition, which is a major health problem in modern
society,  also  causes  metabolic  dysfunction  in  skeletal  muscle  and  predisposition  to  metabolic  disease.  It  is  now  the
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changes in calcium flux, nervous system inputs, and 
transcriptional events and is a dynamic process. 
Endurance exercise increases oxidative capacity of 
skeletal muscle, and to this end, human studies have 
shown that endurance athletes have increased amounts 
of MHC type I [2]. During periods of inactivity, fibers 
switch from oxidative to more glycolytic types [4]. 
Furthermore, an increased proportion of glycolytic 
fibers have been demonstrated in the elderly population 
as well as diet-induced obese populations [2, 3]. 
However, it is not well understood whether these 
changes in myofiber content are causal to age- and 
overnutrition-induced obesity and insulin resistance, or 
whether they are merely consequences of these events. 
 
One hallmark of the aging process is the progressive 
atrophy of skeletal muscle leading to weakness and 
frailness, a condition termed sarcopenia, which is also 
associated with increased obesity in elderly [5]. It is 


































is related to a switch in myofiber composition, a loss of 
muscle stem cell number, and decreased mitochondrial 
function [6, 7]. To this end, mitochondrial number and 
function decreases with age in human subjects [8, 9]. 
Numerous hypotheses have surfaced as to why 
mitochondrial function decreases with age. These 
hypotheses include increased reactive oxygen species 
(ROS) production, chronic inflammation and/or 
mitochondrial DNA damage [8, 10-14]. One may draw 
many comparisons between the decline in skeletal 
muscle function that occurs with aging and 
mitochondrial dysfunction in the skeletal muscle of 
individuals that consume high levels of calories. Recent 
work has demonstrated that mitochondrial damage 
occurs in obesity due to enhanced ROS and chronic 
inflammation caused by increased fatty acid load [15-
17]. These data suggest that modulation of fatty acid-
driven signaling pathways, inflammatory pathways, or 
ROS may prevent mitochondrial damage and thus, 
enhance skeletal muscle oxidative capacity, therefore 
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function and their impact on aging  
 
Calcineurin/NFAT – Through transgenic and knockout 
mouse models, calcineurin, a calcium-activated 
phosphatase (also known as protein phosphatase 2B), 
has been shown to be necessary to drive the slow twitch 
MHC phenotype [18-20]. Calcineurin does this by 
controlling the phosphorylation status of a transcription 
factor called nuclear factor of activated T-cells (NFAT), 
which is activated upon dephosphorylation. Active 
NFAT enhances transcription of genes that promote a 
slow-twitch myofiber phenotype [18, 21]. Interestingly, 
calcineurin has been demonstrated to increase in 
activity with age in a ROS-dependent manner, and 
correlates with age-induced muscle dysfunction [22].   
 
MAP Kinases – The MAPKs consist of growth factor-
regulated extracellular signal related kinases 1 and 2 
(ERK1/2), and the stress-activated MAPKs, c-jun NH2-
terminal kinase (JNK) and p38 MAPK [23]. MAPKs 
are activated by phosphorylation on regulatory tyrosine 
and threonine residues by upstream MAP kinase kinases 
(MKKs), and are inactivated by dephosphorylation on 
these same regulatory residues by MAPK phosphatases 
(MKPs) [23, 24]. Although it is appreciated that 
MAPKs play an essential role in myogenesis, relatively 
little is known about the involvement of the MAPKs in 
fiber type establishment. A role for ERK1/2 has been 
demonstrated in slow-fiber type expression, as 
constitutively active Ras increases MHC type I 
expression [25]. There is also evidence that p38 MAPK 
is able to drive MHC type IIx (intermediate) gene 
expression in myoblasts [26]. 
 
Increased MAPK activity after exercise has been shown 
to be important for exercise-mediated gene expression, 
which may contribute to the role of exercise 
ameliorating the effects of aging in skeletal muscle [27]. 
Though the contribution of MAPKs in aging has not 
been convincingly addressed in vertebrates, some 
studies in drosophila as well as c. elegans have 
demonstrated a role for MAPKs for enhancement of 
lifespan. Whereas the role of p38 MAPK in promotion 
of lifespan is controversial [28, 29], JNK activity 
enhances lifespan by antagonizing insulin signaling [30, 
31]. Additionally, decreased ERK1/2 activity 
throughout aging is known to promote senescence [32]. 
These data suggest the possibility that decreased MAPK 
activity during aging may have deleterious effects on 
metabolic health and lifespan. 
 
PGC-1α – The transcriptional co-activator peroxisome 
proliferator-activated receptor gamma co-activator 1-α 
(PGC-1α) drives mitochondrial biogenesis and function 
and additionally is important in the cellular defense 
against reactive oxygen species [33, 34].  Specifically, 
in skeletal muscle, the expression of PGC-1α drives not 
only mitochondrial biogenesis and oxidative myofiber 
establishment but also vascularization [35-37]. It has 
been found that a high fat diet or fatty acid treatment 
causes a reduction in the expression of PGC-1α and 
other mitochondrial genes in skeletal muscle [38-40], 
which may be a mechanism through which excess 
caloric intake impairs skeletal muscle function.  
 
Recent work has also demonstrated that transgenic 
overexpression of PGC-1α in skeletal muscle improves 
sarcopenia and obesity associated with aging in mice 
[41]. This implies that pharmacological control of 
stability or expression of PGC-1α may be a therapeutic 
option for the elderly to ameliorate metabolic 
dysfunction. Pharmacological modulation of protein 
stability remains somewhat challenging and so 
alternative strategies targeting regulators of PGC-1α 
function are likely to meet with more success. Stability 
of PGC-1α has been shown to be driven by both 
acetylation as well as phosphorylation [42, 43]. Stability 
and activity of PGC-1α is enhanced by phosphorylation 
by p38 MAPK [43] which again raises the interesting 
issue of the role of the MAPKs in both sarcopenia and 
in responses to overnutrition. 
 
MAP Kinase Phosphatases – MKPs are dual-specificity 
phosphatases that constitute a sub-family of the protein 
tyrosine phosphatase (PTP) superfamily [44]. MKPs are 
classified into three subgroups based on subcellular 
localization, tissue distribution and substrate preference 
[44, 45]. MKP-1 is the founding member of this family 
of enzymes and is a nuclear-localized, immediate-early 
gene that is responsive to numerous stimuli including 
ROS, cytokines, growth factors, and fatty acids [15, 46]. 
MKP-1 expression is confined to the nucleus and 
therefore is restricted to the dephosphorylation of the 
nuclear pool of active MAPKs [47]. Though MKP-1 has 
the ability to dephosphorylate all three MAPKs, it 
displays substrate preference to the stress-responsive 
MAPKs, p38 MAPK and JNK [48, 49].   
 
As discussed, enhanced ROS, cytokines and fatty acids 
can induce the expression of MKP-1 [15, 46]. 
Therefore, it is conceivable that increased MKP-1 
expression in response to stresses such as these might 
play a role in the demise of skeletal muscle 
mitochondrial function. Indeed, we had provided the 
first insight into a potential connection between 
mitochondrial function and MKP-1 [47]. We showed 
that in mice lacking MKP-1 mitochondrial oxidative 
phosphorylation was enhanced in the oxidative portions 
of skeletal muscle [47]. Consistent with this MKP-1-
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expenditure and were resistant to diet-induced obesity 
[47]. These results provide genetic evidence that MKP-
1 is connected, through modulation of the MAPKs, to 
mitochondrial function in skeletal muscle as well as 
whole body energetics. It is tempting to speculate that 
age- and diet-induced stresses that promote deleterious 
mitochondrial function could be attributed to the 
convergence, at least in part, to the overexpression of 
MKP-1 in skeletal muscle. 
 
More recently we have been able to provide mechanistic 
insight in to the pathway linking MKP-1 to 
mitochondrial function. We have found that MKP-1 is a 
key regulator of the master controller of mitochondrial 
biogenesis, PGC-1α [15]. When mice are fed a high-fat 
diet, the expression levels of MKP-1 in skeletal muscle 
increase which results in a reduction in PGC-1α levels. 
In contrast, PGC-1α levels are maintained in mice 
lacking MKP-1 [15]. Consistent with the notion that 
PGC-1α promotes oxidative myofiber composition 
MKP-1-deficient mice are refractory to the switch from 
oxidative to glycolytic myofibers seen in wild type mice 
fed a high fat diet and remain lean. These observations 
support the idea that MKP-1 plays an important role in 
maintaining skeletal muscle health. Mechanistically, 
MKP-1 appears to control a pool of nuclear p38 MAPK 
activity that is responsible for phosphorylating PGC-1α 
on residues that promote its stability. Therefore, 
increased MKP-1 expression levels result in a reduction 
of p38 MAPK-mediated PGC-1α phosphorylation and 
ultimately, stability. Collectively, these observations 
raise the possibility that impairment in mitochondrial 
function might arise through disturbing the dynamic 
homeostatic balance between MKP-1 and p38 MAPK 
activity in the nucleus. The precise contribution of 
MKP-1, as well as other MKPs which have the capacity 
to dephosphorylate p38 MAPK in the nucleus, to 
mitochondrial dysfunction in either aging or 
overnutrition still remains to be fully realized. 
Nevertheless, these recent insights provide a platform 
from which these questions can be addressed. 
 
Phosphatases in aging 
 
The role of PTPs in the aging process is largely 
unknown. On a broad scale, enhanced phosphatase 
activity has been associated with cellular senescence 
[32, 50]. It is also recognized that ROS, which inhibit 
PTPs by modification of the catalytic cysteine [51], are 
increased during the aging process. The enhanced levels 
of ROS during aging are likely due to the increased 
production of pro-inflammatory cytokines [13, 52], and 
reduced antioxidant defenses [13]. However, even 
though ROS inhibit phosphatase activity, enhanced 
ROS levels are also known to drive cellular senescence 
[53], suggesting a potential role for PTPs both in 
promoting as well as inhibiting senescence. ROS also 
elicits a cellular stress response, which may induce 
stress-responsive phosphatases, such as the MKPs, to 
serve as negative regulators of excessive MAPK 
activity [54, 55]. More studies are warranted to 
determine what role enhanced ROS in a whole organism 
has on modulation of PTP activity during aging.  
 
In support of the data that similar mechanisms are at 
work in overnutrition as well as age-induced metabolic 
dysfunction, our laboratory has demonstrated that mice 
lacking MKP-1 are resistant to age-induced obesity, in 
the absence of a high fat diet [47]. Moreover, MKP-1 
expression in skeletal muscle of aged human patients 
has been shown to be enhanced [56]. Though the 
mechanisms behind the resistance to age-induced 
obesity in mice lacking MKP-1 have not yet been 
defined, one may hypothesize that similar mechanisms 
also apply as those in a high fat diet scenario.  For 
example, increases in cellular insults such as ROS and 
intramyocellular lipids, which increase during aging 
[57, 58], may trigger increased MKP-1expression, thus 
negatively regulating p38 MAPK activity, and 
therefore, PGC-1α stability. Consistent with this notion, 
as previously discussed, PGC-1α expression is 
sufficient to relieve rodents of age-related sarcopenia 
[41]. It is unclear however, how ROS may promote 
increased levels of MKP-1 expression without affecting 
catalytic activity. Nevertheless, modulation of p38 
MAPK activity by MKP-1 may be important in the 
progression of age-related sarcopenia and obesity.   
 
Treatments for sarcopenia 
 
Caloric Restriction – Calorie restriction is perhaps the 
most well recognized anti-aging therapy, and exerts this 
effect in multiple ways [13]. Calorie restriction has an 
anti-inflammatory effect and is important for decreasing 
oxidant production during aging [13]. In addition, 
calorie restriction is associated with decreased MAPK 
activity [13]. Provocatively, calorie restriction may 
serve to prevent the reported increase in MKP-1 levels 
during aging. Increased MKP-1 levels during aging 
would reduce PGC-1α levels thereby removing the 
protective effects of stressors on skeletal muscle. 
Calorie restriction also activates the deacetylase SIRT1, 
which is a positive regulator of longevity in c. elegans 
[59]. To this end, SIRT1 also promotes PGC-1α activity 
by deacetylation [42], thus demonstrating a role for 
calorie restriction in promotion of PGC-1α activity. 
Interestingly, acetylation is also known to enhance the 
phosphatase function of MKP-1 [60]. One hypothesis 
may be that SIRT1 deacetylates, and therefore decreases 
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function, thus, preventing myofiber dysfunction. 
 
Exercise – Moderate exercise retards the aging process, 
and additionally induces an oxidative muscle phenotype 
[13]. Several hypotheses have arisen regarding the role 
of exercise in aging. Leading hypotheses include the 
fact that a moderate exercise regimen reduces pro-
inflammatory cytokine production and chronic 
inflammation. The reduced level of inflammation leads 
to a decrease in ROS production, which lessens DNA 
damage [13]. Other groups have demonstrated that 
resistance training enhances myofiber size and 
contractility, thus preventing age-mediated myofiber 
loss [61, 62]. Importantly, exercise has been shown to 
induce MAPK activity in skeletal muscle, which is 
important for exercise-mediated gene expression [27]. 
In particular, p38 MAPK is known to drive PGC-1α 
transcription as well as stability in skeletal muscle [43, 
63]. In animals lacking MKP-1 expression, it would be 
important to determine if the enhanced MAPK activity 
in skeletal muscle promotes similar gene expression 
events as exercise. If this is the case, mice lacking 
MKP-1 may exhibit characteristics similar to that of the 




It is now well accepted that aging is an underlying 
predisposition to metabolic disease. Not surprisingly, 
the pathways that succumb to the deleterious effects of 
aging often seem to be those that also control 
metabolism. Protein tyrosine phosphatases have not 
featured as prominent targets for convergence for these 
two pathophysiological processes up until now. MKP-1 
appears to exhibit characteristics that afford it the ability 
to respond to age-related stresses such as increased ROS 
and free fatty acids in skeletal muscle. If in fact MKP-1 
plays a major role in the convergence in skeletal muscle 
between aging and susceptibility to metabolic disease, 
how this phosphatase is regulated by such external 
factors needs to be addressed in significantly more 
depth. One intriguing, and as yet to be tested idea, is 
whether MKP-1 is more deeply intertwined with other 
pathways that control longevity such as the SIRTs. As 
such, it will be interesting to determine whether there is 
a longevity phenotype in mice lacking MKP-1. Clearly, 
these ideas set the stage for further work to be 
conducted on age- and nutrition-related consequences, 
not only on MKP-1, but also other protein tyrosine 
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